Navigation Links
IGI Laboratories Announces Third Quarter 2013 Results
Date:10/29/2013

BUENA, N.J., Oct. 29, 2013 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced its financial results for the third quarter ended September 30, 2013.

(Logo: http://photos.prnewswire.com/prnh/20130827/MM70487LOGO)

Third Quarter and Year to Date 2013 Highlights

  • Total revenues of $4.0 million in the third quarter of 2013, an increase of 100% over the same quarter in 2012
  • Total revenues of $11.5 million for the nine months ended September 30, 2013, an increase of 84% over the same period in 2012
  • Total net revenues generated from the sale of IGI label generic topical pharmaceutical products for the three and nine months ended September 30, 2013 were $1.4 million, and $4.2 million, respectively
  • Gross profit remained consistent year over year, equaling 31.0% for the nine months ended September 30, 2013 from 31.7% in the same period of 2012
  • IGI filed its eleventh and twelfth Abbreviated Drug Application, or ANDA, with the U.S. Food and Drug Administration (FDA) on July 24, 2013 and September 18, 2013 respectively
  • Net loss was $0.1 million and $1.4 million in the third quarter of 2013 and 2012, respectively
  • Net loss included research and development costs of $0.7 million and $0.6 million in the third quarter of 2013 and 2012, respectively
  • Net loss was $0.8 million and $2.7 million for the nine months ended September 30, 2013 and 2012, respectively
  • IGI's President and Chief Executive Officer, Jason Grenfell-Gardner, stated, "Our team has done a tremendous job this quarter.  This quarter marks the fifth consecutive quarter of top line growth.  Our net loss is rapidly approaching break even for the first time at IGI in over twenty-two quarters.  We have solidified our market position in our first
    '/>"/>

    SOURCE IGI Laboratories, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
    2. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
    3. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
    4. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
    5. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
    6. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
    7. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
    8. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
    9. Court Preliminarily Deems Millennium Laboratories Press Release Misleading
    10. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
    11. Carl Icahn Issues Letter To Howard Solomon Of Forest Laboratories
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... LAWRENCEVILLE, N.J. , July 31, 2014  Celsion ... the Company will host a conference call to discuss ... EDT on Thursday, August 7, 2014. To participate in ... North America ) or 1-785-830-1924 (International/Toll) and ask ... (Conference Code: 8283269) to register ten minutes before the ...
    (Date:7/31/2014)... , 31. Juli 2014 Marken ... Miami bekanntgegeben, um die wachsenden ... und Lateinamerika zu erfüllen. Die neu ausgebaute Einrichtung ... Proben und für die Zusammenlegung von Sendungen in ... zusätzliche Lagerkapazität bereitstellen.   Logo - ...
    (Date:7/31/2014)... LAVAL, Quebec, July 31, 2014   , 2014 ... over the prior year , Overall organic growth was 4% ... facial injectable products; Bausch + Lomb grew 12% , ... increase of 43% , 2014 Second Quarter GAAP Operating ... , Highlights of the Second Quarter , Launched ...
    Breaking Medicine Technology:Celsion Corporation to Hold Second Quarter 2014 Financial Results 2Marken erweitert regionales Logistikzentrum in Miami 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32
    ... June 14, 2011 /PRNewswire-iReach/ -- URINOZINC® ... (Photo:   http://photos.prnewswire.com/prnh/20110614/CG20097 ) ... available at all corporate-owned GNC Live Well stores ... 1935, GNC has more than 6,000 stores spread ...
    ... Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... filed an Abbreviated New Drug Application (ANDA) with ... approval to market Olopatadine Hydrochloride Ophthalmic Solution USP, ... is a generic version of Alcon, Inc.,s Pataday™ ...
    Cached Medicine Technology:Patented URINOZINC® Prostate Formula Now Available at GNC Stores 2Patented URINOZINC® Prostate Formula Now Available at GNC Stores 3Watson Confirms Pataday™ Patent Challenge 2Watson Confirms Pataday™ Patent Challenge 3
    (Date:7/31/2014)... (PRWEB) July 31, 2014 Ticket Down ... at Levi’s Stadium in Santa Clara, California. Fans in the ... see some of the best club and national teams in the ... to Brazil, this has become the best time to be a ... and special events being held on American soil this year, as ...
    (Date:7/31/2014)... 2014 David Kekich, anti-aging icon ... ) is thrilled that the acceptance of his ... Artificial Intelligence (AI) algorithms and then screening thousands ... acceptance. , “It took longer than ... proof is in," said Kekich. "Client acceptance is ...
    (Date:7/31/2014)... July 31, 2014 Much of the liver,s metabolic ... body clock and UC Irvine researchers have now ... The study, published online today in Cell , ... metabolism and points the way to more focused drug ... obesity and diabetes. , Paolo Sassone-Corsi, UCI,s Donald Bren ...
    (Date:7/31/2014)... July 31, 2014 BioProcess ... delivering cutting-edge information focused on the development ... launched its newly designed website, http://www.bioprocessintl.com ... by providing visitors specialized content under upstream ... business areas. As the site is updated ...
    (Date:7/31/2014)... -- Many teens never outgrow their "growing pains," according ... for years, affecting teens, participation in sports and other ... growing pains can become chronic, the researchers cautioned. ... three young people between the ages of 12 and ... Michael Skovdal Rathleff, a physiotherapist from Aarhus University. "Seven ...
    Breaking Medicine News(10 mins):Health News:Mexico vs. Chile Tickets Levi’s Stadium: Ticket Down Slashes Ticket Prices for Chile vs. Mexico at Levi’s Stadium in Santa Clara, California on September 6th 2Health News:Mexico vs. Chile Tickets Levi’s Stadium: Ticket Down Slashes Ticket Prices for Chile vs. Mexico at Levi’s Stadium in Santa Clara, California on September 6th 3Health News:MaxLife Solution™ Expands Distribution Globally for Breakthrough Anti-Inflammatory Support Supplement – InflaGene™ 2Health News:Strict genomic partitioning by biological clock separates key metabolic functions 2Health News:BioProcess International Launches New Website 2Health News:Teen 'Growing Pains' May Persist For Years 2
    ... University of Southern ... Angeles County Hospital, STEINBACH, Manitoba, Feb. 4 Partnered ... of Santa Monica, MCM,served as the millwork provider for the ... highly detailed work involving a large,number of custom nursing stations ...
    ... MCM,s Biggest Project Completed With Detailed Precision, ... a joint,venture of Pei Architects and Perkins & ... replacement hospital in Westwood, the Ronald,Reagan UCLA Medical ... Angeles,California. Featuring over 70,000 square feet of wall ...
    ... deficits , , MONDAY, Feb. 4 (HealthDay News) -- Eye ... during pregnancy but who don,t have the distinctive facial ... suggests. , "Eyeblink conditioning (EBC) is a Pavlovian ... such as a tone, with an unconditioned stimulus, such ...
    ... Renowned esthetician, Karen,Dunlap, has developed an advanced ... the number-one most nutritious and powerful food,in the ... between science and,nature, Dunlap discovered that topical application ... its benefits. Her new signature facial, the,Acai Berry ...
    ... Progen,Pharmaceuticals, Management Team (ASX: PGL; Nasdaq: PGLA) will ... 9.00am,Australian (Sydney time) and Monday 4 February at 5:00pm ... overview of the Cellgate, Inc.,acquisition and will be available ... refer to the relevant presentation at: http://www.progen-pharma.com , ...
    ... Trust for America,s,Health warns that the proposed 7 percent ... (CDC) in the president,s fiscal year 2009,budget could harm ... CDC would fall to a six year low for ... are skyrocketing, we should be,investing more to keep Americans ...
    Cached Medicine News:Health News:MCM Completes LAC+USC Replacement Medical Facility Project 2Health News:Eye Blinks May ID Fetal Alcohol Exposure 2Health News:Breakthrough 'Acai Berry Anti-Aging Facial' Applies Benefits of Nature's Super-Food to the Skin 2Health News:Progen Investor Teleconference Dial In Details 2Health News:Cuts to HHS Could Leave Americans' Health in Critical Condition, TFAH Says; New Poll Shows Americans Believe Disease Prevention is Key to Reducing Healthcare Costs 2
    ... The iCycler thermal cycler maximizes what ... laboratory. It features multiple sample formats, an ... direct upgradability to real-time quantitative PCR. The ... of what a thermal cycler can do ...
    ... small footprint, simple intuitive programming and almost ... the ideal personal cycler in the modern ... and the self-adjusting heated lid allows a ... vessels or a microplate of 5 x ...
    ... The system includes: Mx3005P instrument ... choice of five (5) filters. The ... I (492nm-516nm), HEX/JOE/VIC (535nm-555nm), ROX/Texas Red ... Also included: desktop computer, Mx3005P analysis ...
    ... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...
    Medicine Products: